Vaccination With Autologous Dendritic Cells Pulsed With Tumor Antigens for Treatment of Patients With Malignant Melanoma.Phase I/II Study.
Latest Information Update: 18 Sep 2021
At a glance
- Drugs Melanoma vaccine (Primary) ; Celecoxib; Cyclophosphamide; Interleukin-2
- Indications Malignant melanoma
- Focus Adverse reactions; Therapeutic Use
- 27 Apr 2010 Actual end date (Apr 2010) added as reported by ClinicalTrials.gov.
- 27 Apr 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 26 Apr 2010 Biomarkers information updated